Results 181 to 190 of about 16,883 (239)

Cohort profile: the pharmacogenomics and pharmacokinetics study in Ghanaian HIV patients (GenoPharm-GH). [PDF]

BMC Genom Data
Thomford NE, Ryabinina O, Twum JA, Anyimadu J, Nyarko SB, Anyanful A, Ekor M, Kyei GB.   +7 more
europepmc   +1 more source

Pharmacoeconomic perspectives on HIV: integrating data for long-term treatment and prevention. [PDF]

Front Med (Lausanne)
Mursal M, Fatima G, Gushchina YS.
europepmc   +1 more source

Virological failure in a pediatric cohort on a dolutegravir based regimen: a retrospective study in northwest Ethiopia, 2017-2023. [PDF]

Front Pediatr
Zewdu WS, Zeleke MM, Ferede YA, Kassie AB, Alemu MA, Moges TA.   +5 more
europepmc   +1 more source

HIV-1 drug resistance among people living with HIV receiving dolutegravir-based anti-retroviral regimens in Uganda: a national laboratory-based survey using remnant viral load samples, 2022. [PDF]

J Antimicrob Chemother
Watera C, Da Silva JF, Namayanja G, Asio JN, Ssemwanga D, Pals S, Nabukenya M, Raizes E, Nanyonjo M, Elur B, Nazziwa E, Sanyu G, Ayitewala A, Ssali M, Katureebe C, Balidawa H, Zheng DP, Zeh C, Hackett S, Mwangi C, Naluguza M, Ntale J, Katongole Mbidde E, Kaleebu P.   +23 more
europepmc   +1 more source

Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trial.

Lancet Glob Health
Kiguba R, Ndagije HB, Mwebaza N, Ssenyonga R, Giibwa L, Isabirye G, Owiny J, Nambasa V, Ntale I, Atuhaire J, Mwesigwa D, Mayengo J, Walusimbi D, Mugisa I, Katureebe C, Harrison K, Karamagi C, Pirmohamed M.   +17 more
europepmc   +1 more source